Best nephrologists: TOP 102 doctors

Nephrologist, organ transplant surgeon

Urologist

Head of the Glickman Urological and Kidney Institute

• Specializes in declining renal function and genetic kidney diseases.
• International training includes Medical School of the University of Vienna.
• Focus on aftercare for kidney transplanted patients.
• Addresses complications of diabetes mellitus in the kidney.
• Holds a medical degree with a focus on Nephrology.
• Member of professional medical societies.
• Offers consultations for patients with kidney-related issues.

Nephrologist, kidney transplant specialist

Prof. Salvatore Badalamenti is the Nephrology and Dialysis Unit Director in Humanitas Research Hospital. He has graduated at the Università degli Studi of Milan and is specialised in Medical Nephrology, Liver Diseases and Replacement.

Medical areas of interest:

• clinical nephrology and dialysis, chronic renal failure and its complications (anemia, osteodystrophy)
• preparation of vascular access for hemodialysis
• acid-base balance disorders. continuous renal replacement therapy in intensive care (CRRT)
• hepatorenal syndrome
• emergency medicine

Previous experience:

1990-1995 Polyclinic Hospital, Milan, Italy
He was a Staff grade specialist. Focused on infectious complications in dialysis treatments, particularly hepatitis C and anaemia, and nephrological and dialysis emergencies.

1986-1990 Provincial Hospital Clinic , Barcelona, Spain
He completed his PhD in Renal and Hepatic pathophysiology. Especially focused on the study of renal complications in patients with liver disease.

Research areas of interest: 

• clinical nephrology
• anemia and erythropoietin in renal failure and dialysis
• continuous renal replacement therapy in intensive care (crrt)
• hepatorenal syndrome. 
• phgosis and pentraxine in renal failure

He is a member of the Board of Directors of the Italian Society of Nephrology (SIN)

Teaching experience:

He is Professor of Internal Medicine and Emergency medicine and Professor of Nephrology at Università degli Studi of Milan.

Biography

Dr. Mehdi Afrit is a Medical Oncologist who practices at Burjeel Specialty Hospital in Sharjah. He has over 11 years of experience caring for and managing cancer patients. He has extensive experience providing chemotherapy, hormonal therapy, immunotherapy, and targeted therapy to patients. He earned a Certificate of Medical Oncology from the Gustave Roussy Institute in Paris, France, where he received training in antitumor chemotherapy and cancer medical treatment. Additionally, he holds an international certificate in breast diseases. He also has a certificate in Good Clinical Practice from Trans Celerate Biopharma Inc. and a certificate in Clinical Trial Management: Good Clinical Practice from the Faculty of Pharmaceutical Medicine of the Royal College of Physicians. He previously worked for over five years as an Assistant Professor of Medical Oncology at Tunis’s Faculty of Medicine. He later practiced as a Consultant, Medical Oncologist for six years at Arianna’s hospital in Tunisia. He later worked for two years as a Specialist Medical Oncologist at Zulekha Hospital. He was also an investigator in three international clinical trials and holds clinical trial auditing and CRO certifications and a GCP Training Certificate from 2016. He is a member in good standing of the Emirates Oncology Society (EOS), the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). His clinical expertise includes but is not limited to the following:

• Oncology care and treatment for chemotherapy, hormonal therapy, immune therapy, and target therapy
• Breast cancer
• Solid tumor diagnosis
• Digestive cancer
• Gynecological cancer
• Lung cancer
• Genitourinary cancer
• Sarcoma

Awards & Achievements

• Award from Himaya Foundations and University of Sharjah

Research & Publications

• Clinicopathological Features of Gastric Cancer in a Cohort of Gulf Council Countries' Patients: A Cross-Sectional Study of 96 Cases. Journal of Oncology Research Reviews & Reports Volume 2(2): 1-3.
• The Burden of Gynecologic Cancers in the UAE. Journal of Oncology Research Reviews & Reports Volume 2(4): 1-6.
• The Emirates Oncology Task Force Clinical Practice Guideline on Screening for SARS-CoV-2 in Asymptomatic Adult Cancer Patients Before Anti-Cancer Therapy. Journal of Oncology Research Reviews & Reports Volume 2(4): 1-6.
• The State of Cancer Care in the United Arab Emirates in 2020: Challenges and Recommendations, A report by the United Arab Emirates Oncology Task Force. Humaid Al-Shamsi, Humaa Darr, Ibrahim Abu-Gheida , Jawaher Ansari, Martine, Mehdi Afrit, Mohamad H Masri, Mohamed Abuhaleeqa. Gulf J Oncology 2020 Jan;1(32):71-87.
• Primary Bone Lymphoma: Tunisian Multicentric Retrospective Study About 32 Cases. Ben Ayed C, Laabidi S, Said N, Afrit M, Ben Ahmed S, Boussen H. Tunis Med. 2018 May;96(5):269-272.
• First Site of Recurrence After Breast Cancer Adjuvant Treatment in the Era of Multimodality Therapy: Which Imaging for Which Patient During Follow-up? Nesrine M, Mehdi B, Houda EB, Soumaya L, Mehdi A, Bechir Z, Hamouda B. Breast Dis. 2017 Nov 21